Differences in Efficacy Between Gamithromycin, Tilmicosin, and Tulathromycin as Metaphylactic Treatments in High Risk Calves for Bovine Respiratory Disease by Miller, T. et al.
Kansas Agricultural Experiment Station Research Reports 
Volume 3 
Issue 1 Cattlemen's Day Article 11 
January 2017 
Differences in Efficacy Between Gamithromycin, Tilmicosin, and 
Tulathromycin as Metaphylactic Treatments in High Risk Calves 
for Bovine Respiratory Disease 
T. Miller 
Kansas State University, Manhattan 
M. E. Hubbert 
New Mexico State University, Las Cruces, NM 
E. F. Schwandt 
Kansas State University, Manhattan, eschwandt@k-state.edu 
See next page for additional authors 
This report is brought to you for free and open access by New 
Prairie Press. It has been accepted for inclusion in Kansas 
Agricultural Experiment Station Research Reports by an 
authorized administrator of New Prairie Press. Copyright 
January 2017 Kansas State University Agricultural Experiment 
Station and Cooperative Extension Service. Contents of this 
publication may be freely reproduced for educational purposes. 
All other rights reserved. Brand names appearing in this 
publication are for product identification purposes only. No 
endorsement is intended, nor is criticism implied of similar 
products not mentioned. K-State Research and Extension is an 
equal opportunity provider and employer. 
Follow this and additional works at: https://newprairiepress.org/kaesrr 
 Part of the Large or Food Animal and Equine Medicine Commons, Other Animal Sciences Commons, 
and the Veterinary Infectious Diseases Commons 
Recommended Citation 
Miller, T.; Hubbert, M. E.; Schwandt, E. F.; Thomson, D. U.; and Reinhardt, C. D. (2017) "Differences in 
Efficacy Between Gamithromycin, Tilmicosin, and Tulathromycin as Metaphylactic Treatments in High 
Risk Calves for Bovine Respiratory Disease," Kansas Agricultural Experiment Station Research Reports: 
Vol. 3: Iss. 1. https://doi.org/10.4148/2378-5977.1345 
Differences in Efficacy Between Gamithromycin, Tilmicosin, and Tulathromycin 
as Metaphylactic Treatments in High Risk Calves for Bovine Respiratory Disease 
Abstract 
The cost of Bovine Respiratory Disease to the beef industry due to death, poorer conversions, and therapy 
is estimated to cost more than $3 billion per year. Identifying and mitigating Bovine Respiratory Disease in 
cattle can be difficult due to the increased susceptibility for Bovine Respiratory Disease in high risk cattle. 
One management option to minimize an outbreak of respiratory disease is the use of metaphylaxis, the 
mass treatment of a group of calves to reduce the incidence and adverse effects of respiratory disease 
on high risk animals. Criteria used to determine the necessity of metaphylactic treatment against Bovine 
Respiratory Disease in feedlots can be based on several factors depending on feedlot preference; 
however, the primary criteria often considered are: a known history of no previous vaccinations, overall 
appearance of cattle, source of cattle, Bovine Respiratory Disease in calves received from same source 
previously, long shipping distance, season of the year, and light arrival weight. 
The objective of this study was to compare the efficacy of treating newly received, highrisk feedlot calves 
with gamithromycin, tulathromycin, and tilmicosin as metaphylactic treatments on health and 
performance characteristics. 
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Differences in Efficacy Between 
Gamithromycin, Tilmicosin, and 
Tulathromycin as Metaphylactic  
Treatments in High Risk Calves for  
Bovine Respiratory Disease
T. Miller, M. E. Hubbert1, E.F. Schwandt, D.U. Thomson,  
and C.D. Reinhardt 
Introduction
The cost of Bovine Respiratory Disease to the beef industry due to death, poorer con-
versions, and therapy is estimated to cost more than $3 billion per year. Identifying and 
mitigating Bovine Respiratory Disease in cattle can be difficult due to the increased 
susceptibility for Bovine Respiratory Disease in high risk cattle. One management op-
tion to minimize an outbreak of respiratory disease is the use of metaphylaxis, the mass 
treatment of a group of calves to reduce the incidence and adverse effects of respiratory 
disease on high risk animals. Criteria used to determine the necessity of metaphylactic 
treatment against Bovine Respiratory Disease in feedlots can be based on several factors 
depending on feedlot preference; however, the primary criteria often considered are: a 
known history of no previous vaccinations, overall appearance of cattle, source of cattle, 
Bovine Respiratory Disease in calves received from same source previously, long ship-
ping distance, season of the year, and light arrival weight. 
The objective of this study was to compare the efficacy of treating newly received, high-
risk feedlot calves with gamithromycin, tulathromycin, and tilmicosin as metaphylactic 
treatments on health and performance characteristics.
Key words: bovine respiratory disease, cattle, metaphylactic treatment
Experimental Procedures
Cross-bred heifer calves (n = 572; initial body weight 404 ± 27.4 lb) were used in a 
randomized complete block design to evaluate the effects of three different metaphy-
lactic treatments for Bovine Respiratory Disease in high risk calves upon arrival at the 
feedlot. Cattle originated from the Southeastern United States and were shipped ap-
proximately 700 mi. to the research center. Cattle were delivered in five individual loads 
over a 17-day period and were identified as high-risk due to being light-weight calves 
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from a sale barn origin, co-mingled, and long truck haul (>8 hours on the truck). Each 
load (114 to 120 animals per load) was unloaded and heifers were weighed individually 
before being placed in an arrival pen. Cattle received free-choice long-stemmed hay, a 
minimal amount (<1.0 lb/head as fed) of starter ration, and ad libitum access to water 
for the first 24 to 48 hours.
After a 24 to 48 hour rest, heifers were individually weighed, vaccinated with Bovishield 
Gold 5, Inforce 3, and were given Dectomax (Zoetis Animal Health, Florham Park, 
NJ), Valbazen (Zoetis Animal Health, Florham Park, NJ), and Synovex C (Zoetis Ani-
mal Health, Florham Park, NJ). Horns (for heifers with horns) were tipped to approxi-
mately 1 in. diameter. Each animal received an individual identification ear tag and a 
tag identifying treatment assignment. Heifers were housed by treatment in soil-surfaced 
pens (40 × 115 ft, with 36 ft bunk line; 19 to 20 animals/pen) with approximately 22 
in. of bunk space per animal. Water was supplied to each pen with a bunk line continu-
ous flow water tank. 
Within each arrival group, heifers in groups of three were randomly assigned to re-
ceive one of the three metaphylactic treatments during processing. Administrators 
of metaphylactic treatments were blinded to treatment. The selected antibiotic was 
injected subcutaneously in the neck per label dosage and site of administration rec-
ommendations. The treatments administered consisted of one of the three follow-
ing antibiotics: 1) tulathromycin (1.13 mg/lb; 192 calves); 2) tilmicosin phosphate 
(5.99 mg/lb; 193 calves); or 3) gamithromycin (2.72 mg/lb; 194 calves). Cattle were 
randomized into 5 blocks with 3 treatment groups within each block and 10 replicates 
per treatment. Thirty pens were filled with approximately 19 to 20 heifers. Individual 
weights were recorded on day 0 and pen weights recorded at the end of the trial on days 
56 to 60. Pen served as the experimental unit.
Heifers were initially fed a receiving diet composed of 20% dry-rolled corn, 57% wet 
corn gluten feed, 18% ground corn stalks, and 5% of a supplement containing deco-
quinate. Dietary energy concentrations were increased through day 28 using a 2-ration 
(starter diet and grower diet) transition system. The grower diet was composed of 30% 
ground corn, 52% wet corn gluten feed, 13% ground corn stalks, and 5% of a supple-
ment containing lasalocid. Feed was delivered to the bunks twice daily by way of an 
auger mixer wagon. Throughout the feeding period, cattle were offered feed ad libitum 
with an attempt to minimize the amount of feed left over before the next feeding pe-
riod. 
Individual animal health was assessed daily throughout the study. Clinical monitor-
ing of study heifers was performed at the same time each day by trained animal health 
personnel that were blinded to treatments. Any animal pulled with a combined score 
≥ 3 and a rectal temperature ≥ 104°F was treated with ceftiofur crystalline free acid, 
according to label directions, with a 5-day post-treatment interval so that no retreat-
ment was allowed until 5 days following the original treatment. Any animal removed 
from the pen for treatment with a combined score ≥ 3 and a rectal temperature < 104°F 
was treated with enrofloxacin, according to label directions, and a 3-day post-treatment 
moratorium. Any animal removed from the pen for treatment with a combined score < 
3 was not treated and was returned to its home pen. Any animal removed from the pen 
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for treatment a second time was treated with ceftiofur crystalline free acid as the second 
treatment; however, if the animal received ceftiofur crystalline free acid as its first treat-
ment, then enrofloxacin was used as the second treatment. Sick animals were returned 
to their home pen following treatment. Animals were removed from the study if severe 
clinical morbidity prior to expiration of the assigned moratorium occurred. 
Average daily gain, average daily feed intake, morbidity, and mortality measurements 
were evaluated on a pen means basis as a randomized complete block design and ana-
lyzed using the PROC MIXED procedure of SAS (SAS Institute, Inc., Cary, NC). 
Treatment was included in the model as a fixed effect; pen was the experimental 
unit for all measures. Average daily gain and feed efficiency were calculated on both 
deads in and deads out basis across treatment groups. Means were generated with the 
LSMEANS statement and separated using the PDIFF function when the F-statistic was 
significant (P<0.05). Morbidity, mortality, and retreatments were analyzed as percent-
age of the pen using a Wilcoxon Rank-Sum Test.
Results and Discussion
A total of 7 animals were removed from the study: two were removed due to lameness,  
three were removed due to animal welfare concerns based on severe clinical morbidity 
prior to expiration of the assigned moratorium, and two were removed due to suspected 
neurological symptoms. 
Heifer performance results are presented in Table 1. There were no differences between 
treatments for dry matter intake or feed:gain (P>0.05) during the experimental pe-
riod. Heifers administered tulathromycin had greater average daily gain compared to 
gamithromycin treated heifers. There were no differences in average daily gain between 
gamithromycin and tilmicosin treated heifers (P>0.05). There were no differences in av-
erage daily gain or dry matter intake between the tulathromycin and tilmicosin treated 
heifers. 
Calves that received tulathromycin had reduced (P<0.05) morbidity rates compared 
to those that received tilmicosin and gamithromycin (Table 2). No differences were 
found in morbidity between tilmicosin-treated calves and gamithromycin-treated calves 
(P>0.05). Mortality rates were low across all treatment groups and there were no treat-
ment differences (P>0.05) for mortality or second treatment rate. Calves treated with 
tulathromycin were 0.36 and 0.40 times as likely to get sick compared to tilmicosin-
treated calves and gamithromycin-treated calves, respectively. 
Implications
There are differences between antimicrobials with respect to effectiveness in suppressing 
bovine respiratory disease when used as a mass medication immediately upon arrival.
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Table 1. Least squares means illustrating the effects of metaphylactic treatments on 
newly received, high-risk feedlot calves on animal performance
Treatment1
Item2 Tulathromycin3 Tilmicosin3 Gamithromycin3 SEM4
Initial weight, lb 403.5 402.7 405.1 3.295
Final weight, lb 553.0 544.3 540.1 8.283
Dry matter intake, lb 12.52 12.28 11.99 0.198
Average daily gain, lb
Deads in 2.54a,x 2.36a,b,y 2.25b,x,y 0.105
Deads out 2.62a 2.48a,b 2.36b 0.089
Feed:gain
Deads in 4.96 5.29 5.43 0.257
Deads out 4.82 5.01 5.10 0.165
1Tulathromycin (1.13 mg/lb); Tilmicosin (5.99 mg/lb); and Gamithromycin (2.72 mg/lb). 
2Least squares treatment means.
3Means within a row without a common superscript of a,b,c are different (P<0.05) or a common superscript of x, y, 
or z have a tendency (P<0.10).
4Standard error of the least squares mean.
Table 2. Comparative health effects of metaphylactic treatments on newly received, high-risk feedlot calves 




intervalItem Tulathromycin Tilmicosin Gamithromycin Risk ratio P-value
Number of cattle 192 193 194
Mortality 2 (1.0%) 3 (1.5%) 0.67 -3.34-2.34 0.72
2 (1.0%) 3 (1.6%) 0.67 -3.36-2.31 0.71
3 (1.6%) 3 (1.5%) 1.01 -2.81-2.86 0.99
Morbidity
1st treatment 10 (5.2%) 25 (12.8%) 0.40 9.30-19.95 0.05
10 (5.2%) 28 (14.6%) 0.36 -0.17-10.48 0.02
28 (14.6%) 25 (12.8%) 1.13 7.47-18.11 0.62
2nd treatment 0 (0.0%) 3 (1.5%) - -3.79-0.79 0.19
0 (0.0%) 5 (2.6%) - -4.85-0.27 0.03
5 (2.6%) 3 (1.5%) 1.68 -1.23-3.35 0.35
1 Tulathromycin (1.13 mg/lb), Tilmicosin (5.99 mg/lb), and Gamithromycin (2.72 mg/lb).
